Novel endoscopic therapeutic modalities for superficial neoplasms arising in Barrett's esophagus: A primer for surgical pathologists

Modern Pathology

Volumn 22, Issue 4, 2009, Pages 489-498

  Lauwers, Gregory Y ^a   Forcione, David G ^a   Nishioka, Norman S ^a   Deshpande, Vikram ^a   Lisovsky, Mikhail Y ^a   Brugge, William R ^a   Mino Kenudson, Mari ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Barretts esophagus; Endoscopic therapy; High grade dysplasia; Intramucosal adenocarcinoma

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN;

BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL TRIAL; DYSPLASIA; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL DYSPLASIA; ESOPHAGUS RESECTION; HISTOPATHOLOGY; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MEDICAL PRACTICE; MEDICAL SPECIALIST; MULTICENTER STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TACHYCARDIA;

BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS; PATHOLOGY, SURGICAL; PHOTOCHEMOTHERAPY;

EID: 63949087202     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.4     Document Type: Review

References (72)

1. Reed MF, Tolis Jr G, Edil BH, et al. Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg 2005;79:1110-1115; discussion-5.
2. Holscher AH, Bollschweiler E, Schroder W, et al. Prognostic differences between early squamous-cell and adenocarcinoma of the esophagus. Dis Esophagus 1997;10:179-184.
3. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-1137.
4. Stein HJ, Feith M, Mueller J, et al. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg 2000;232:733-742.
5. Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999;117:16-23; discussion-5.
6. Rice TW, Zuccaro Jr G, Adelstein DJ, et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 1998;65:787-792.
7. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 2003;58:183-188.
8. Attwood SE, Lewis CJ, Caplin S, et al. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol 2003;1:258-263.
9. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118: 670-677.
10. Ban S, Mino M, Nishioka NS, et al. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol 2004;28:1466-1473.
11. May A, Gossner L, Behrens A, et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 2003;58:167-175.
12. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc 2000;52:328-332.
13. Ell C, May A, Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007;65:3-10.
14. Mino-Kenudson M, Brugge WR, Puricelli WP, et al. Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol 2005;29:680-686.
15. Hamada T, Kondo K, Itagaki Y, et al. Endoscopic mucosal resection for early gastric cancer. Nippon Rinsho 1996;54:1292-1297.
16. Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001;48:225-229.
17. Mizumoto S, Misumi A, Harada K, et al. Evaluation of endoscopic mucosal resection (EMR) as a curative therapy against early gastric cancer. Nippon Geka Gakkai Zasshi 1992;93:1071-1074.
18. Rice TW, Blackstone EH, Goldblum JR, et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001;122:1077-1090.
19. Takeshita K, Tani M, Inoue H, et al. Endoscopic treatment of early oesophageal or gastric cancer. Gut 1997; 40:123-127.
20. Ahmad NA, Kochman ML, Long WB, et al. Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc 2002;55:390-396.
21. Giovannini M, Bernardini D, Moutardier V, et al. Endoscopic mucosal resection (EMR): results and prognostic factors in 21 patients. Endoscopy 1999; 31:698-701.
22. Vieth M, Ell C, Gossner L, et al. Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. Endoscopy 2004;36:776-781.
23. Ponchon T, Ciorirlan M, Saurin J-C. Endoscopic mucosal resection for superficial esophageal neoplastic lesion; comparison between macroscopic, histological, and follow-up results. Gastrointest Endosc 2004; 59:AB253 (W1549).
24. Lewis J, Lutzke L, Smyrk T. The limitations of endoscopic mucosal resection in Barrett's esophagus. Gastrointest Endosc 2004;59:AB101 (Abstract 401).
25. Pacifico RJ, Wang KK, Wongkeesong LM, et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol 2003;1:252-257.
26. Prasad GA, Buttar NS, Wongkeesong LM, et al. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol 2007;102:2380-2386.
27. Mitsuhashi T, Lauwers GY, Ban S, et al. Post-gastric endoscopic mucosal resection surveillance biopsies: evaluation of mucosal changes and recognition of potential mimics of residual adenocarcinoma. Am J Surg Pathol 2006;30:650-656.
28. Lauwers GY, Ban S, Mino M, et al. Endoscopic mucosal resection for gastric epithelial neoplasms: a study of 39 cases with emphasis on the evaluation of specimens and recommendations for optimal pathologic analysis. Mod Pathol 2004;17:2-8.
29. Conio M, Repici A, Cestari R, et al. Endoscopic mucosal resection for high-grade dysplasia and intra- Endoscopic therapeutic modalities for neoplasms in Barrett's esophagus GY Lauwers et al 496 Modern Pathology (2009) 22, 489-498 mucosal carcinoma occurring in Barrett's esophagus. Gastrointest Endosc 2004;59:AB253.
30. Hull MJ, Mino-Kenudson M, Nishioka NS, et al. Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg Pathol 2006;30:114-118.
31. Liu L, Hofstetter WL, Rashid A, et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 2005;29: 1079-1085.
32. Stein HJ, Feith M, Bruecher BL, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005;242:566-573; discussion 73-5.
33. Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005;446:497-504.
34. Oh DS, Hagen JA, Chandrasoma PT, et al. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg 2006;203:152-161.
35. Scotiniotis IA, Kochman ML, Lewis JD, et al. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc 2001;54:689-696.
36. Larghi A, Lightdale CJ, Memeo L, et al. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc 2005;62:16-23.
37. Mandal RV, Forcione DG, Brugge WR, et al. Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia. Am J Surg Pathol; 26 November 2008 [e-pub ahead of print].
38. Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003;58:S3-43.
39. Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999;117:16-23; discussion-5.
40. Lewis JT, Wang KK, Abraham SC. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for Barrett esophagus: implications for staging of adenocarcinoma. Am J Surg Pathol 2008;32:566-571.
41. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001;32:368-378.
42. Mino-Kenudson M, Hull MJ, Brown I, et al. Endoscopic mucosal resection as a diagnostic modality: interrater diagnostic correlation for endoscopic mucosal resection specimens is better than biopsy specimens. Gastroenterology 2006;130:A410.
43. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993;85: 443-456.
44. Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005;62:488-498.
45. Wolfsen HC, Woodward TA, Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 2002;77:1176-1181.
46. Wang KK. Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc 1999;49: S20-S23.
47. Wang KK, Sampliner RE. Mucosal ablation therapy of Barrett esophagus. Mayo Clin Proc 2001;76: 433-437.
48. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999;49:1-7.
49. Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448-455.
50. Ackroyd R, Brown NJ, Davis MF, et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut 2000;47:612-617.
51. Pech O, Gossner L, May A, et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 2005;62:24-30.
52. Foroulis CN, Thorpe JA. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Eur J Cardiothorac Surg 2006;29:30-34.
53. Lauwers GY, personal data. Biddlestone LR, Barham CP, Wilkinson SP, et al. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol 1998;22:239-245.
54. Van Laethem JL, Cremer M, Peny MO, et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 1998;43:747-751.
55. Barham CP, Jones RL, Biddlestone LR, et al. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous reepithelialisation. Gut 1997;41:281-284.
56. Mino-Kenudson M, Lauwers GY. Pathology of Barrett's esophagus after photodynamic therapy. Mod Pathol 2007;20:A550.
57. Peters F, Kara M, Rosmolen W, et al. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in Barrett esophagus after endoscopic resection. Endoscopy 2005;37:418-424.
58. Mino-Kenudson M, Ohana M, Ban S, et al. Barrett esophagus associated neoplasms treated by photodynamic therapy: determination of limiting factors (Abstract 517). Lab Invest 2006;86:114A.
59. Shirvani VN, Ouatu-Lascar R, Kaur BS, et al. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology 2000;118:487-496.
60. Hamoui N, Peters JH, Schneider S, et al. Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus. Arch Surg 2004;139:712-716; discussion 6-7.
61. Paulson TG, Reid BJ. Focus on Barrett's esophagus and esophageal adenocarcinoma. Cancer Cell 2004;6: 11-16.
62. Wolfsen HC, Hemminger LL, Wallace MB, et al.Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.Aliment Pharmacol Ther 2004;20:1125-1131.
63. Barr H, Shepherd NA, Dix A, et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996; 348:584-585.
64. Ackroyd R, Kelty CJ, Brown NJ, et al. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. Endoscopy 2003;35:496-501.
65. Van Laethem JL, Peny MO, Salmon I, et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 2000; 46:574-577.
66. Sharma P. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia. Semin Gastrointest Dis 1999;10:93-102.
67. Mino-Kenudson M, Ban S, Ohana M, et al. Buried dysplasia and early adenocarcinoma arising in Barrett's esophagus after porfimer-photodynamic therapy. Am J Surg Pathol 2007;31:403-409.
68. Sharma VK, Wang KK, Overholt BF, et al. Balloonbased, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007;65:185-195.
69. Ganz RA, Overholt BF, Sharma VK, et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a US Multicenter Registry. Gastrointest Endosc 2008;68:35-40.
70. Sharma VK, Kim HJ, Musil D, et al. Circumferential ablation of Barrett esophagus with low grade dysplasia: one and two year follow-up of the AIM-LGD trial. Gastrointest Endosc 2007;65:AB155.
71. Johnston MH, Cash BD, Horwhat JD, et al. Cryoablation of Barrett's esophagus. Gastroenterology 2006;130:A640.
72. Pouw RE, Gondrie JJ, Sondermeijer C, et al. Novel combined modality therapy for Barrett's esophagus containing high-grade dysplasia: endoscopic mucosal resection followed by circumferential and focal ablation using the HALO system. Gastrointest Endosc 2007;65:AB111.